(Q66079811)

English

Real-world Comparative Effectiveness of Stroke Prevention in Patients With Atrial Fibrillation Treated With Rivaroxaban vs. Vitamin k Antagonists

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

Real-world Comparative Effectiveness of Stroke Prevention in Patients With Atrial Fibrillation Treated With Rivaroxaban vs. Vitamin k Antagonists (English)

0 references

0 references

0 references

15 October 2016

0 references

end time

31 December 2016

0 references

number of participants

99,999

0 references

research intervention

(E)-phytonadione

0 references

minimum age

18 year

0 references

study type

observational study

0 references

Identifiers

ClinicalTrials.gov ID

NCT02960880

0 references

(Q66079811)

Real-world Comparative Effectiveness of Stroke Prevention in Patients With Atrial Fibrillation Treated With Rivaroxaban vs. Vitamin k Antagonists

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)